- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Secondary Progress Multiple Sclerosis in United Kingdom
Total 1464 results
-
BayerCompletedMultiple SclerosisSwitzerland, France, Germany, Indonesia, Korea, Republic of, Spain, Sweden, Thailand, Taiwan, Australia, Austria, Colombia, Czech Republic, Italy, Jordan, Kazakhstan, Lebanon, Mexico, Slovenia, United Kingdom, Bahrain, Egypt, United... and more
-
BiogenRecruitingRelapsing Forms of Multiple SclerosisSpain, United States, Italy, Switzerland, Germany, Bulgaria, Czechia, Poland, Puerto Rico, Romania
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Israel, United States, Canada, France, Switzerland, Ireland, Italy, Australia, Spain, Austria, Germany, Brazil, Netherlands, Poland, Russian Federation, Hungary, Slovenia, Argentina, Ukraine, Greece, Sweden, Finland, Latvia, No... and more
-
SanofiActive, not recruitingRelapsing Multiple SclerosisSpain, United States, Mexico, Japan, Austria, Belarus, Bulgaria, Canada, China, Czechia, Denmark, Estonia, Finland, Germany, Italy, Lithuania, Poland, Romania, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, Hong Kong
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Israel, Sweden, United States, France, Switzerland, Ireland, Canada, Australia, Brazil, Austria, Poland, Germany, Hungary, Netherlands, Russian Federation, Spain, Argentina, Slovenia, Greece, Finland, Denmark, Ukraine, Italy, L... and more
-
Hoffmann-La RocheActive, not recruitingRelapsing Multiple SclerosisUnited States, Mexico, Hungary, China, Germany, Italy, Peru, Poland, Portugal, Russian Federation, Spain, Switzerland, Ukraine, Tunisia, Netherlands, Argentina, Georgia, Hong Kong, Kenya, Dominican Republic, Finland, North Macedonia, Serb...
-
The University of Texas at DallasUniversity of Texas Southwestern Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenElan PharmaceuticalsCompletedSafety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingUnited States, Germany, Austria, Belgium, France, Israel, Italy
-
University of VirginiaChildren's Hospital of PhiladelphiaRecruiting
-
University of California, San FranciscoNot yet recruitingDemyelinating Diseases | Clinically Isolated Syndrome, CNS Demyelinating | Multiple Sclerosis Brain Lesion | Multiple Sclerosis Acute and Progressive | Demyelination; Corpus CallosumUnited States
-
Johns Hopkins UniversityPatient-Centered Outcomes Research Institute; National Multiple Sclerosis SocietyRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Opexa Therapeutics, Inc.TerminatedClinically Isolated Syndrome | Multiple Sclerosis, Relapsing-RemittingUnited States
-
University of Texas Southwestern Medical CenterBiogenCompletedMultiple Sclerosis (MS)United States
-
BiogenCompleted
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Puerto Rico
-
BiogenCompletedMultiple SclerosisSweden, United Kingdom, Netherlands, Belgium, Canada, Italy
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisUnited States, Canada, Puerto Rico
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompletedMultiple SclerosisRussian Federation, Sweden, Germany, Poland, Hungary, United Kingdom, Netherlands, Switzerland, Turkey, Czechia
-
NovartisCompletedMultiple SclerosisSwitzerland, Germany, Spain, Portugal, Canada, Denmark, Finland, France, Italy, Poland, United Kingdom
-
Clene NanomedicineClene Australia Pty LtdTerminatedRelapsing Remitting Multiple Sclerosis | Optic Neuropathy | Optic; Neuritis, With DemyelinationUnited States, Canada, Australia
-
George Washington UniversityCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Oxford Brookes UniversityGuy's and St Thomas' NHS Foundation Trust; Oxford University Hospitals NHS... and other collaboratorsRecruitingMultiple Sclerosis | Neuromyelitis OpticaUnited Kingdom
-
Nuffield Orthopaedic Centre NHS TrustOxford Brookes UniversityCompletedStroke | Multiple Sclerosis | Brain InjuryUnited Kingdom
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing Multiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Israel, Italy, Lithuania, North Macedonia, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Ukraine
-
TG Therapeutics, Inc.RecruitingRelapsing Multiple SclerosisUnited States
-
Wellspect HealthCareWellspect HealthCareRecruitingMultiple Sclerosis | Fecal Incontinence | Neurogenic Bowel (Disorder) | Fecal ConstipationDenmark, Switzerland, United Kingdom, France, Spain
-
Solent NHS TrustCompletedMultiple Sclerosis | Cerebral Palsy | Respiratory System | Intrathecal BaclofenUnited Kingdom
-
Merz Pharmaceuticals GmbHTerminatedMultiple Sclerosis | Nystagmus, Congenital | Nystagmus, AcquiredUnited Kingdom
-
SanofiCompletedMultiple SclerosisUkraine, Russian Federation, Estonia, Czech Republic, Denmark, Finland, France, Turkey, United Kingdom, United States, Portugal, Austria, Canada, Chile, Germany, Italy, Netherlands, Norway, Poland, Sweden, Switzerland
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationRecruitingMultiple SclerosisUnited States, Belgium, France, Germany, Spain, United Kingdom, Italy
-
Kessler FoundationInstituto Vocacional Enrique Díaz de León A.C., Guadalajara, MexicoRecruitingTBI (Traumatic Brain Injury) or MS (Multiple Sclerosis)United States, Spain
-
Brown, Theodore R., M.D., MPHEvergreen HealthcareCompletedErythema | MS (Multiple Sclerosis)United States
-
BiogenTerminatedMultiple SclerosisUnited States, Italy, Switzerland, United Kingdom, Czechia, France
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | RRMSSpain, Czechia, Germany, Australia, Italy, Switzerland, Denmark, United States, United Kingdom, Canada, Netherlands, Poland
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...CompletedMultiple SclerosisUnited Kingdom, Germany, Finland, Israel, Spain, Canada, France, Australia, Czechia, Austria, Sweden, Poland, Hungary, Italy
-
Hoffmann-La RocheWithdrawnMultiple SclerosisSpain, United Kingdom, Czech Republic, Canada, Germany, Slovakia, Poland, Bulgaria, Russian Federation
-
Brainstorm-Cell TherapeuticsCompletedMultiple Sclerosis, Chronic ProgressiveUnited States
-
AbbVie (prior sponsor, Abbott)CompletedMultiple SclerosisUnited States, Canada, Germany, Netherlands, United Kingdom
-
Hoffmann-La RochePPD; Laboratory Corporation of America; Illingworth Research GroupActive, not recruitingMultiple Sclerosis | Clinically Isolated SyndromeUnited States, Spain, United Kingdom, Germany
-
Jazz PharmaceuticalsRecruitingTuberous Sclerosis Complex Associated Neuropsychiatric DiseaseUnited States, United Kingdom, Poland
-
University of NottinghamCompletedTuberous Sclerosis | LymphangioleiomyomatosisUnited Kingdom
-
Novartis PharmaceuticalsRecruitingMultiple SclerosisGermany, Spain, Italy, France, United Kingdom
-
EMD SeronoCompletedMultiple SclerosisUnited States, Australia, France, Italy, Turkey, United Kingdom, Austria, Germany, Israel, Argentina, Norway, Spain
-
University of Illinois at ChicagoRecruitingMultiple SclerosisUnited States
-
MGH Institute of Health ProfessionsNot yet recruitingMultiple SclerosisUnited States
-
Hunter College of City University of New YorkRecruiting
-
Icahn School of Medicine at Mount SinaiDoris Duke Charitable FoundationRecruiting
-
Brigham and Women's HospitalGenentech, Inc.; Boston Medical CenterNot yet recruiting